Johnson & Johnson is putting its money where its mouth is, investing $100 million in a fund that aims to make a difference in the lives of women, children, and adolescents around the world, the New York Times reports.
The Women's and Children's Health Technology Fund, or CBIV, is a partnership between Johnson & Johnson's philanthropic arm, the Johnson & Johnson Foundation, and Germany's state-owned financial institution, KfW.
According to a press release, the fund will invest in technology companies that "make health systems more resilient" or "address women's, children's, and adolescents' or make health systems more accessible."
Companies in CBIV's portfolio include Daye, which has created a tampon-based diagnostic platform for conditions such as cervical cancer; Onco Health, which provides digital health platform for cancer patients; and OCIO Bivium Westfuller, which provides neonatal ultrasound services.
"Our current portfolio has the potential to make a difference in the lives of millions of women, children, and adolescents in North America and Europe, in addition to targeting underserved populations in emerging markets," Donna Parr, a managing partner at CBIV, says in the press release.
Read the Entire Article
A customized collection of news from foundations from around the Web.
A part of a series produced by The Huffington Post in celebration of #GivingTuesday, which will take place this year on December 3, Kathy Calvin and Henry Timms vouch that we are living in a new era of philanthropy.